Bluejay Diagnostics, Inc. (BJDX) Financials
BJDX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 8.2 million | 3.0 million |
| 2023-06-30 | 8.5 million | 2.1 million |
| 2023-03-31 | 10.9 million | 1.7 million |
| 2022-12-31 | 13.5 million | 2.0 million |
BJDX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -1.2 million | -42483 |
| 2023-06-30 | -1.7 million | 27704 |
| 2023-03-31 | -3.3 million | 219589 |
| 2022-12-31 | -3.2 million | 87586 |
BJDX Net Income
No data available :(
BJDX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 5.1 million | - | 388809 |
| 2023-06-30 | 5.1 million | - | 424019 |
| 2023-03-31 | 6.8 million | - | 458619 |
| 2022-12-31 | 10.1 million | - | 508444 |
BJDX Shares Outstanding
BJDX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 74498 | 1.4 million | 963534 | 19619 |
| 2023-06-30 | 201105 | 1.7 million | 1.1 million | 154329 |
| 2023-03-31 | 340669 | 1.4 million | 1.2 million | 148046 |
| 2022-12-31 | 238207 | 1.3 million | 961888 | 170277 |
BJDX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 270785 |
| 2023-06-30 | - | 293502 |
| 2023-03-31 | - | 160345 |
| 2022-12-31 | 249040 | 68925 |
BJDX
Price: $0.55
52 week price:
Earnings Per Share: -9.08 USD
P/E Ratio: -0.08
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 114300
Market Capitalization: 1.7 million